Literature DB >> 31327263

Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence.

Mohammed Siddiqui1, Eric K Judd2, Tanja Dudenbostel1, Bin Zhang3,4, Pankaj Gupta5,6, Maciej Tomaszewski7, Prashanth Patel5,6, Suzanne Oparil1, David A Calhoun1.   

Abstract

Masked uncontrolled hypertension (MUCH) in treated hypertensive patients is defined as controlled automated office blood pressure (BP; <135/85 mm Hg) in-clinic but uncontrolled out-of-clinic BP by ambulatory BP monitoring (awake [daytime] readings ≥135/85 mm Hg or 24-hour readings ≥130/80 mm Hg). To determine whether MUCH is attributable to antihypertensive medication nonadherence. One hundred eighty-four enrolled patients were confirmed to have controlled office BP; of these, 167 patients were with adequate 24-hour ambulatory BP recordings. Of 167 patients, 86 were controlled by in-clinic BP assessment but had uncontrolled ambulatory awake BP, indicative of MUCH. The remaining 81 had controlled in-clinic and ambulatory awake BP, consistent with true controlled hypertension. After exclusion of 9 patients with missing 24-hour urine collections, antihypertensive medication adherence was determined based on the detection of urinary drugs or drug metabolites by high-performance liquid chromatography-tandem mass spectrometry. Of the 81 patients with MUCH, 69 (85.2%) were fully adherent and 12 (14.8%) were partially adherent (fewer medications detected than prescribed). Of the 77 patients with true controlled hypertension, 69 (89.6%) were fully adherent with prescribed antihypertensive medications and 8 (10.4%) were partially adherent. None of the patients in either group were fully nonadherent. There was no statistically significant difference in complete or partial adherence between the MUCH and true controlled groups (P=0.403). Measurement of urinary drug and drug metabolite levels demonstrates a similarly high level of antihypertensive medication adherence in both MUCH and truly controlled hypertensive patients. These findings indicate that MUCH is not attributable to antihypertensive medication nonadherence.

Entities:  

Keywords:  blood pressure; humans; hypertension; medication adherence

Mesh:

Substances:

Year:  2019        PMID: 31327263      PMCID: PMC6687528          DOI: 10.1161/HYPERTENSIONAHA.119.13258

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  52 in total

1.  Overall accuracy of the BpTRU--an automated electronic blood pressure device.

Authors:  Gurdial S Mattu; Balraj S Heran; James M Wright
Journal:  Blood Press Monit       Date:  2004-02       Impact factor: 1.444

2.  Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.

Authors:  Paul E Drawz; Arnold B Alper; Amanda H Anderson; Carolyn S Brecklin; Jeanne Charleston; Jing Chen; Rajat Deo; Michael J Fischer; Jiang He; Chi-Yuan Hsu; Yonghong Huan; Martin G Keane; John W Kusek; Gail K Makos; Edgar R Miller; Elsayed Z Soliman; Susan P Steigerwalt; Jonathan J Taliercio; Raymond R Townsend; Matthew R Weir; Jackson T Wright; Dawei Xie; Mahboob Rahman
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-18       Impact factor: 8.237

3.  Out-of-Clinic Sympathetic Activity Is Increased in Patients With Masked Uncontrolled Hypertension.

Authors:  Mohammed Siddiqui; Eric K Judd; Byron C Jaeger; Hemal Bhatt; Tanja Dudenbostel; Bin Zhang; Lloyd J Edwards; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

4.  Changes of blood pressure patterns and target organ damage in patients with chronic kidney disease: results of the APrODiTe-2 study.

Authors:  Ran-Hui Cha; Hajeong Lee; Jung Pyo Lee; Eunjeong Kang; Young Rim Song; Yon Su Kim; Sung Gyun Kim
Journal:  J Hypertens       Date:  2017-03       Impact factor: 4.844

Review 5.  Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association.

Authors:  Paul Muntner; Daichi Shimbo; Robert M Carey; Jeanne B Charleston; Trudy Gaillard; Sanjay Misra; Martin G Myers; Gbenga Ogedegbe; Joseph E Schwartz; Raymond R Townsend; Elaine M Urbina; Anthony J Viera; William B White; Jackson T Wright
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

6.  Masked Uncontrolled Hypertension in CKD.

Authors:  Rajiv Agarwal; Maria K Pappas; Arjun D Sinha
Journal:  J Am Soc Nephrol       Date:  2015-07-10       Impact factor: 10.121

7.  Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

8.  Neurogenic abnormalities in masked hypertension.

Authors:  Guido Grassi; Gino Seravalle; Fosca Quarti Trevano; Raffaella Dell'oro; Gianbattista Bolla; Cesare Cuspidi; Francesca Arenare; Giuseppe Mancia
Journal:  Hypertension       Date:  2007-07-09       Impact factor: 10.190

9.  Epidemiological perspective of body position and arm level in blood pressure measurement.

Authors:  A Terént; E Breig-Asberg
Journal:  Blood Press       Date:  1994-05       Impact factor: 2.835

10.  Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis.

Authors:  Branislav Strauch; Ondřej Petrák; Tomáš Zelinka; Ján Rosa; Zuzana Somlóová; Tomáš Indra; Lukáš Chytil; Věra Marešová; Ivana Kurcová; Robert Holaj; Dan Wichterle; Jiří Widimský
Journal:  J Hypertens       Date:  2013-12       Impact factor: 4.844

View more
  4 in total

1.  Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Mahboob Rahman; Xue Wang; Joshua D Bundy; Jeanne Charleston; Debbie Cohen; Jordana Cohen; Paul E Drawz; Lama Ghazi; Edward Horowitz; James P Lash; Sarah Schrauben; Matthew R Weir; Dawei Xie; Raymond R Townsend
Journal:  J Am Soc Nephrol       Date:  2020-09-24       Impact factor: 10.121

2.  Masked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone Secretion.

Authors:  Mohammed Siddiqui; Eric K Judd; Bin Zhang; Tanja Dudenbostel; Robert M Carey; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2020-12-07       Impact factor: 10.190

3.  Twenty-Four-Hour Ambulatory Blood Pressure Monitoring.

Authors:  Camilo Pena-Hernandez; Kenneth Nugent; Meryem Tuncel
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

Review 4.  Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta-Analysis Involving 27 Million Patients.

Authors:  Eric K P Lee; Paul Poon; Benjamin H K Yip; Yacong Bo; Meng-Ting Zhu; Chun-Pong Yu; Alfonse C H Ngai; Martin C S Wong; Samuel Y S Wong
Journal:  J Am Heart Assoc       Date:  2022-09-03       Impact factor: 6.106

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.